CAS: 1613313-01-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Rovalpituzumab REF: TM-T76698CAS: 1613313-01-1 | > 95% | 171.00 €~1,968.00 € | Tue 07 Jan 25 |
 | Rovalpituzumab REF: 3D-CLA1404CAS: 1613313-01-1 | - - - | To inquire | Wed 15 Jan 25 |
Rovalpituzumab
CAS:1613313-01-1
Rovalpituzumab: humanized antibody against DLL3, forms ADCs, treats small cell lung cancer.
Purity:
> 95%
Color and Shape:
Liquid
Molecular weight:
145.02 kDa
- Inhibitors
- Neuroscience
- Stem Cell and Derivatives
- Stem Cells
- See more categories
- Gamma-secretase
Ref: TM-T76698
| 1mg | 171.00 € | ||
| 5mg | 441.00 € | ||
| 10mg | 702.00 € | ||
| 25mg | 1,093.00 € | ||
| 50mg | 1,458.00 € | ||
| 100mg | 1,968.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 3D-CLA1404
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
